John Paulson insider trades

Open-market stock purchases and sales by John Paulson, Director at Bausch Health Companies Inc, from SEC Form 4 filings since May 11, 2016.

Track record: 29% of 21 scored buys are up 5% or more since purchase, averaging -20%.

Recent trades

DateStockTradeValue
Sep 30, 2026BHC Bausch Health Companies IncBought (not open market)$62.5K
Jun 30, 2026BHC Bausch Health Companies IncBought (not open market)$62.5K
Jun 12, 2026AAMI Acadian Asset Management IncBought (not open market)—
May 26, 2026BLCO Bausch & Lomb CorpBought (not open market)$250K
May 22, 2026BHC Bausch Health Companies IncBought (not open market)—
May 14, 2026AAMI Acadian Asset Management IncBought (not open market)—
Apr 30, 2026BLCO Bausch & Lomb CorpBought (not open market)$21.9K
Mar 31, 2026BHC Bausch Health Companies IncBought (not open market)$62.5K
Feb 19, 2026BLCO Bausch & Lomb CorpBought (not open market)$21.9K
Dec 31, 2025BHC Bausch Health Companies IncBought (not open market)—
Nov 14, 2025BLCO Bausch & Lomb CorpBought (not open market)$21.9K

Companies traded

  • BHC Bausch Health Companies Inc: 20 buys, last Sep 30, 2026
  • AAMI Acadian Asset Management Inc: other filings, last Jun 12, 2026
  • BLCO Bausch & Lomb Corp: other filings, last May 26, 2026
  • BSIG BrightSphere Investment Group Inc: 2 buys, 1 sale, last Jun 7, 2024
  • VRX Valeant Pharmaceuticals International, Inc: 2 buys, 2 sales, last Jun 29, 2018
  • AIG American International Group Inc: other filings, last Apr 3, 2017

Get free alerts when John Paulson files a new trade →